261 related articles for article (PubMed ID: 19901961)
1. Discovery of molecular subtypes in leiomyosarcoma through integrative molecular profiling.
Beck AH; Lee CH; Witten DM; Gleason BC; Edris B; Espinosa I; Zhu S; Li R; Montgomery KD; Marinelli RJ; Tibshirani R; Hastie T; Jablons DM; Rubin BP; Fletcher CD; West RB; van de Rijn M
Oncogene; 2010 Feb; 29(6):845-54. PubMed ID: 19901961
[TBL] [Abstract][Full Text] [Related]
2. Expression of subtype-specific group 1 leiomyosarcoma markers in a wide variety of sarcomas by gene expression analysis and immunohistochemistry.
Mills AM; Beck AH; Montgomery KD; Zhu SX; Espinosa I; Lee CH; Subramanian S; Fletcher CD; van de Rijn M; West RB
Am J Surg Pathol; 2011 Apr; 35(4):583-9. PubMed ID: 21412072
[TBL] [Abstract][Full Text] [Related]
3. Progressive loss of myogenic differentiation in leiomyosarcoma has prognostic value.
Demicco EG; Boland GM; Brewer Savannah KJ; Lusby K; Young ED; Ingram D; Watson KL; Bailey M; Guo X; Hornick JL; van de Rijn M; Wang WL; Torres KE; Lev D; Lazar AJ
Histopathology; 2015 Apr; 66(5):627-38. PubMed ID: 24889065
[TBL] [Abstract][Full Text] [Related]
4. Indistinguishable genomic profiles and shared prognostic markers in undifferentiated pleomorphic sarcoma and leiomyosarcoma: different sides of a single coin?
Carneiro A; Francis P; Bendahl PO; Fernebro J; Akerman M; Fletcher C; Rydholm A; Borg A; Nilbert M
Lab Invest; 2009 Jun; 89(6):668-75. PubMed ID: 19290004
[TBL] [Abstract][Full Text] [Related]
5. Integrated histologic and molecular analysis of uterine leiomyosarcoma and 2 benign variants with nuclear atypia.
Gao T; Finkelman BS; Ban Y; Li Y; Yin P; Bulun SE; Lu X; Ha C; Wei JJ
Cancer Sci; 2021 May; 112(5):2046-2059. PubMed ID: 33338329
[TBL] [Abstract][Full Text] [Related]
6. Gene expression profiling in leiomyosarcomas and undifferentiated pleomorphic sarcomas: SRC as a new diagnostic marker.
Villacis RA; Silveira SM; Barros-Filho MC; Marchi FA; Domingues MA; Scapulatempo-Neto C; Aguiar S; Lopes A; Cunha IW; Rogatto SR
PLoS One; 2014; 9(7):e102281. PubMed ID: 25028927
[TBL] [Abstract][Full Text] [Related]
7. TOP2A copy number and TOP2A expression in uterine benign smooth muscle tumours and leiomyosarcoma.
Baiocchi G; Poliseli FL; De Brot L; Mantoan H; Schiavon BN; Faloppa CC; Vassallo J; Soares FA; Cunha IW
J Clin Pathol; 2016 Oct; 69(10):884-9. PubMed ID: 26994023
[TBL] [Abstract][Full Text] [Related]
8. Lineage-defined leiomyosarcoma subtypes emerge years before diagnosis and determine patient survival.
Anderson ND; Babichev Y; Fuligni F; Comitani F; Layeghifard M; Venier RE; Dentro SC; Maheshwari A; Guram S; Wunker C; Thompson JD; Yuki KE; Hou H; Zatzman M; Light N; Bernardini MQ; Wunder JS; Andrulis IL; Ferguson P; Razak ARA; Swallow CJ; Dowling JJ; Al-Awar RS; Marcellus R; Rouzbahman M; Gerstung M; Durocher D; Alexandrov LB; Dickson BC; Gladdy RA; Shlien A
Nat Commun; 2021 Jul; 12(1):4496. PubMed ID: 34301934
[TBL] [Abstract][Full Text] [Related]
9. The prognostic value of tumor-associated macrophages in leiomyosarcoma: a single institution study.
Ganjoo KN; Witten D; Patel M; Espinosa I; La T; Tibshirani R; van de Rijn M; Jacobs C; West RB
Am J Clin Oncol; 2011 Feb; 34(1):82-6. PubMed ID: 23781555
[TBL] [Abstract][Full Text] [Related]
10. Genomic signatures predict poor outcome in undifferentiated pleomorphic sarcomas and leiomyosarcomas.
Silveira SM; Villacis RA; Marchi FA; Barros Filho Mde C; Drigo SA; Neto CS; Lopes A; da Cunha IW; Rogatto SR
PLoS One; 2013; 8(6):e67643. PubMed ID: 23825676
[TBL] [Abstract][Full Text] [Related]
11. An integrated study of aberrant gene copy number and gene expression in GIST and LMS.
Yang D; Ylipaa A; Yang J; Hunt K; Pollock R; Trent J; Yli-Harja O; Shmulevich I; Nykter M; Zhang W
Technol Cancer Res Treat; 2010 Apr; 9(2):171-8. PubMed ID: 20218739
[TBL] [Abstract][Full Text] [Related]
12. Coordinate expression of colony-stimulating factor-1 and colony-stimulating factor-1-related proteins is associated with poor prognosis in gynecological and nongynecological leiomyosarcoma.
Espinosa I; Beck AH; Lee CH; Zhu S; Montgomery KD; Marinelli RJ; Ganjoo KN; Nielsen TO; Gilks CB; West RB; van de Rijn M
Am J Pathol; 2009 Jun; 174(6):2347-56. PubMed ID: 19443701
[TBL] [Abstract][Full Text] [Related]
13. Integrated genomic and transcriptomic analysis revealed mutation patterns of de-differentiated liposarcoma and leiomyosarcoma.
Liu W; Tong H; Zhang C; Zhuang R; Guo H; Lv C; Yang H; Lin Q; Guo X; Wang Z; Wang Y; Shen F; Wang S; Dai C; Wang G; Liu J; Lu W; Zhang Y; Zhou Y
BMC Cancer; 2020 Oct; 20(1):1035. PubMed ID: 33115433
[TBL] [Abstract][Full Text] [Related]
14. Gene copy number profiling of soft-tissue leiomyosarcomas by array-comparative genomic hybridization.
Larramendy ML; Kaur S; Svarvar C; Böhling T; Knuutila S
Cancer Genet Cytogenet; 2006 Sep; 169(2):94-101. PubMed ID: 16938566
[TBL] [Abstract][Full Text] [Related]
15. Oncogenic Gene-Expression Programs in Leiomyosarcoma and Characterization of Conventional, Inflammatory, and Uterogenic Subtypes.
Hemming ML; Fan C; Raut CP; Demetri GD; Armstrong SA; Sicinska E; George S
Mol Cancer Res; 2020 Sep; 18(9):1302-1314. PubMed ID: 32518213
[TBL] [Abstract][Full Text] [Related]
16. ROR2 is a novel prognostic biomarker and a potential therapeutic target in leiomyosarcoma and gastrointestinal stromal tumour.
Edris B; Espinosa I; Mühlenberg T; Mikels A; Lee CH; Steigen SE; Zhu S; Montgomery KD; Lazar AJ; Lev D; Fletcher JA; Beck AH; West RB; Nusse R; van de Rijn M
J Pathol; 2012 Jun; 227(2):223-33. PubMed ID: 22294416
[TBL] [Abstract][Full Text] [Related]
17. Loss of dystrophin is common in uterine leiomyosarcoma: a potential biomarker for clinical application.
Vadasz B; Felicelli C; Feng Y; Yin P; Zhang Q; Bulun S; Wei JJ
Hum Pathol; 2023 Apr; 134():85-91. PubMed ID: 36549601
[TBL] [Abstract][Full Text] [Related]
18. Gene expression signatures differentiate uterine endometrial stromal sarcoma from leiomyosarcoma.
Davidson B; Abeler VM; Hellesylt E; Holth A; Shih IeM; Skeie-Jensen T; Chen L; Yang Y; Wang TL
Gynecol Oncol; 2013 Feb; 128(2):349-55. PubMed ID: 23178314
[TBL] [Abstract][Full Text] [Related]
19. Genetic profiling identifies two classes of soft-tissue leiomyosarcomas with distinct clinical characteristics.
Italiano A; Lagarde P; Brulard C; Terrier P; Laë M; Marques B; Ranchere-Vince D; Michels JJ; Trassard M; Cioffi A; Piperno-Neumann S; Chevreau C; Blay JY; Delcambre C; Isambert N; Penel N; Bay JO; Bonvalot S; Le Cesne A; Coindre JM; Chibon F
Clin Cancer Res; 2013 Mar; 19(5):1190-6. PubMed ID: 23329812
[TBL] [Abstract][Full Text] [Related]
20. Prognostic role of E-cadherin and Vimentin expression in various subtypes of soft tissue leiomyosarcomas.
Tian W; Wang G; Yang J; Pan Y; Ma Y
Med Oncol; 2013 Mar; 30(1):401. PubMed ID: 23292832
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
